News

GSK Sales, Core Earnings Expected to Edge Lower -- Earnings Preview
SALES FORECAST: The U.K. pharmaceutical company is expected to report sales of 7.8 billion pounds ($10.42 billion), according to consensus estimates compiled by the company. For last year's second ...
GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval
Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...
Earnings week ahead: AAPL, MSFT, AMZN, META, BA, XOM, CVX, PFE, MA, V, PYPL, SOFI, and more
Earnings season hits full stride next week, with an expansive slate of reports from tech titans, energy giants, financial ...
Down 18% since September, is it time for me to capitalise on GSK’s bargain-basement share price?
GSK’s share price has fallen a lot in 10 months, which means it could be a huge bargain. I ran the key numbers and examined ...
GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt
GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...